Associated Papers
Novel Biallelic TECRL Gene Variants Associated with Familial Catecholaminergic Polymorphic Ventricular Tachycardia in a Chinese Family with a History of Sudden Cardiac Death.
Li R et al.
The Tohoku Journal of Experimental Medicine, 2025
Arrhythmogenic Potential of Heterozygous TECRL Variants in Type 3 Catecholaminergic Polymorphic Ventricular Tachycardia.
Porretta AP et al.
Jacc. Clinical Electrophysiology, 2025
Catecholaminergic Polymorphic Ventricular Tachycardia: Advancing From Molecular Insights to Preclinical Models.
Schneider L et al.
Journal of the American Heart Association, 2025
Identification of a novel TECRL variant causing type 3 catecholaminergic polymorphic ventricular tachycardia.
Chen Y et al.
Frontiers in Pediatrics, 2025
Novel variants in TECRL leading to catecholaminergic polymorphic ventricular tachycardia.
Jones D et al.
Life Science Alliance, 2024
Trans-2,3-enoyl-CoA reductase-like-related catecholaminergic polymorphic ventricular tachycardia with regular ventricular tachycardia and response to flecainide.
Ebrahim MA et al.
Journal of Cardiovascular Electrophysiology, 2023
Role of non-coding variants in cardiovascular disease.
Heshmatzad K et al.
Journal of Cellular and Molecular Medicine, 2023
Calcium Handling in Inherited Cardiac Diseases: A Focus on Catecholaminergic Polymorphic Ventricular Tachycardia and Hypertrophic Cardiomyopathy.
Zaffran S et al.
International Journal of Molecular Sciences, 2023
TECRL deficiency results in aberrant mitochondrial function in cardiomyocytes.
Hou C et al.
Communications Biology, 2022
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5.
Priori SG et al.
Journal of the American College of Cardiology, 2021
Life-threatening arrhythmias with autosomal recessive TECRL variants.
Webster G et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 2021
Multiallelic rare variants support an oligogenic origin of sudden cardiac death in the young.
Jaouadi H et al.
Herz, 2021
A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family.
Xie L et al.
European Journal of Medical Genetics, 2019
Catecholaminergic polymorphic ventricular tachycardia, an update.
Pérez-Riera AR et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2018
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.
Giacomelli E et al.
Cellular and Molecular Life Sciences : Cmls, 2017
Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.
Brandão KO et al.
Disease Models & Mechanisms, 2017
Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.
Casini S et al.
Cardiovascular Drugs and Therapy, 2017
TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.
Devalla HD et al.
Embo Molecular Medicine, 2016
Precision medicine in catecholaminergic polymorphic ventricular tachycardia: Recent advances toward personalized care.
Siu A et al.
Annals of Pediatric Cardiology, 0